Tell FDA: Make Lung Cancer a Priority

(October 4, 2012)

The American Lung Association is committed to finding a cure for lung cancer, and needs your help in letting the Food and Drug Administration (FDA) know lung cancer must be a top priority. The FDA is launching a new patient-focused drug development initiative and is asking patients and the American public about their priorities for treatments and cures for diseases. Now is your chance to speak up for a lung cancer cure.

Lung cancer kills more than 160,000 people every year in the U.S. That’s more than any other form of cancer. Lung cancer is also one of the most common cancers and has one of the lowest survival rates. Each year, more than 226,000 new cases are diagnosed, but tragically, only 15 percent of lung cancers are diagnosed at an early stage, when treatment with current medications and therapies is most successful.

You can help change this. If the FDA prioritizes the review of lung cancer cures and treatments as part of their new initiative, we could help turn the tide against America’s number one cancer killer. New research has already shown us that innovative cancer treatments that tailor drugs to specific genetic lung cancer mutations have the potential to save lives. But greater focus and more investment are needed. FDA needs to hear from you that cures and treatments for lung cancer must be a priority.

Please tell FDA that lung cancer cures and treatments must be a priority. Sending your message to the FDA will only take a minute, but it could help change the lives of thousands with lung cancer, and their loved ones.

Want to do more? Please share with your friends and followers.